Citigroup Initiates Coverage of Ascendis Pharma A (ASND) with Buy Recommendation
Fintel reports that on May 19, 2026, Citigroup initiated coverage of Ascendis Pharma A (NasdaqGS:ASND) with a Buy recommendation.
Analyst Price Forecast Suggests 26.79% Upside
As of May 14, 2026, the average one-year price target for Ascendis Pharma A is $301.58/share. The forecasts range from a low of $258.56 to a high of $362.25. The average price target represents an increase of 26.79% from its latest reported closing price of $237.86 / share.
See our leaderboard of companies with the largest price target upside.
The projected annual revenue for Ascendis Pharma A is 1,388MM, an increase of 60.32%. The projected annual non-GAAP EPS is -9.07.
What is the Fund Sentiment?
There are 286 funds or institutions reporting positions in Ascendis Pharma A. This is an decrease of 233 owner(s) or 44.89% in the last quarter. Average portfolio weight of all funds dedicated to ASND is 0.50%, an increase of 26.57%. Total shares owned by institutions decreased in the last three months by 27.33% to 55,774K shares. 
The put/call ratio of ASND is 0.53, indicating a bullish outlook.
What are Other Shareholders Doing?
Ra Capital Management holds 10,281K shares representing 16.55% ownership of the company. No change in the last quarter.
Avoro Capital Advisors holds 5,062K shares representing 8.15% ownership of the company. In its prior filing, the firm reported owning 5,111K shares , representing a decrease of 0.96%. The firm increased its portfolio allocation in ASND by 6.28% over the last quarter.
Westfield Capital Management Co holds 4,813K shares representing 7.75% ownership of the company. In its prior filing, the firm reported owning 5,186K shares , representing a decrease of 7.73%. The firm increased its portfolio allocation in ASND by 0.28% over the last quarter.
Artisan Partners Limited Partnership holds 3,230K shares representing 5.20% ownership of the company. In its prior filing, the firm reported owning 3,226K shares , representing an increase of 0.13%. The firm increased its portfolio allocation in ASND by 15.09% over the last quarter.
Franklin Resources holds 2,052K shares representing 3.30% ownership of the company. In its prior filing, the firm reported owning 1,910K shares , representing an increase of 6.91%. The firm increased its portfolio allocation in ASND by 15.03% over the last quarter.
Fintel is one of the most comprehensive investing research platforms available to individual investors, traders, financial advisors, and small hedge funds.
Our data covers the world, and includes fundamentals, analyst reports, ownership data and fund sentiment, options sentiment, insider trading, options flow, unusual options trades, and much more. Additionally, our exclusive stock picks are powered by advanced, backtested quantitative models for improved profits.
This story originally appeared on Fintel.